ELISA reveals a difference in the structure of substantia nigra ferritin in Parkinson's disease and incidental Lewy body compared to control
- 31 May 2007
- journal article
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 13 (4) , 214-218
- https://doi.org/10.1016/j.parkreldis.2006.10.002
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Iron, brain ageing and neurodegenerative disordersNature Reviews Neuroscience, 2004
- Mössbauer spectroscopy and ELISA studies reveal differences between Parkinson's disease and control substantia nigraBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2003
- The ferritins: molecular properties, iron storage function and cellular regulationPublished by Elsevier ,1999
- Lewy Body DiseaseSouthern Medical Journal, 1996
- Oxygen radicals as key mediators in neurological disease: Fact or fiction?Annals of Neurology, 1992
- Anatomic and Disease Specificity of NADH CoQ1 Reductase (Complex I) Deficiency in Parkinson's DiseaseJournal of Neurochemistry, 1990
- A mutational analysis of the epitopes of recombinant human H-ferritinBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1990
- New Data and a Revised Structural Model for FerrihydriteClays and Clay Minerals, 1988
- Immunochemical characterization of human liver and heart ferritins with monoclonal antibodiesBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1986
- ParkinsonismNeurology, 1967